Host: Rabbit
Target Protein: IL-17RB
Immunogen Range: 351-450/502
Clonality: Polyclonal
Isotype: IgG
Entrez Gene: 55540
Swiss Prot: Q9NRM6
Source: KLH conjugated synthetic peptide derived from human IL-17RB
Purification: Purified by Protein A.
Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage: Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Background:
Size: 100ul
Concentration: 1ug/ul
Applications:
WB(1:300-5000)
ELISA(1:500-1000)
Predicted Molecular Weight: 54
Cross Reactive Species:
Human
Mouse
Rat
For research use only. Not intended for diagnostic or therapeutic use.
- Gregory, Lisa G., et al. "IL-25 drives remodelling in allergic airways disease induced by house dust mite." Thorax 68.1 (2013): 82-90.Read more>>
- Kawamura Teruhiko. et al. Identification of genes associated with endometrial cell ageing. Mol Hum Reprod. 2021 Feb;27(2)Read more>>
- Xie Dong-ping. et al. Effect of Electroacupuncture at Zusanli (ST36) on Sepsis Induced by Cecal Ligation Puncture and Its Relevance to Spleen. Evid-Based Compl Alt. 2020;2020:1914031Read more>>
- Farah Shahjin. et al. Multipolymer microsphere delivery of SARS-CoV-2 antigens. ACTA BIOMATER. 2022 DecRead more>>
L1 rat kidney lysates and L2 rat brain lysates lysates probed with Anti- IL-17RB Polyclonal Antibody, Unconjugated (bs-2610R) at 1:200 in 4˚C. Followed by conjugation to secondary antibody (bs-0295G-HRP) at 1:3000 90min in RT. Predicted band: 33kD/55kD Observed band size: 35kD
Lane 1: Mouse Liver lysates probed with IL-17RB Polyclonal Antibody, Unconjugated (bs-2610R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.
Lane 1: Rat Uterus tissue lysates; Lane 2: Mouse Uterus tissue lysates; Lane 3: Human A549 cell lysates; Lane 4: Human HepG2 cell lysates; Lane 5: Human HeLa cell lysates; Lane 6: Human MCF-7 cell lysates probed with IL17RB Polyclonal Antibody, Unconjugated (bs-2610R) at 1:1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.